HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Beneficial effects of mangiferin on hyperlipidemia in high-fat-fed hamsters.

AbstractSCOPE:
Mangiferin, a natural polyphenol, has been shown to have hypolipidemic effect in rat and mouse. However, the mechanism of action is not well understood. This study was conducted to determine the effect and mechanism of action of mangiferin on hyperlipidemia induced in hamsters by a high-fat diet.
METHODS AND RESULTS:
Forty male hamsters were randomly assigned to normal control, high-fat control, and high fat with mangiferin (50 and 150 mg/kg BW) groups. Mangiferin treatment significantly decreased final body weight, liver weight and visceral fat-pad weight, serum triglyceride (TG) and total free fatty acid (FFA) concentrations, hepatic TG levels and hepatic and muscle total FFA contents. Mangiferin upregulated mRNA expression of peroxisome proliferator-activated receptor-α (PPAR-α), fatty acid translocase (CD36) and carnitine palmitoyltransferase 1 (CPT-1), but downregulated mRNA expression of sterol regulatory element-binding protein 1c (SREBP-1c), acetyl CoA carboxylase (ACC), acyl-CoA:diacylglycerol acyltransferase 2 (DGAT-2) and microsomal triglyceride transfer protein (MTP) in liver. Mangiferin also stimulated mRNA expression of PPAR-α, CD36, CPT-1 and lipoprotein lipase (LPL) in muscle.
CONCLUSIONS:
The results suggest that mangiferin may ameliorate hypertriglyceridemia partly by modulating the expression levels of genes involved in lipid oxidation and lipogenesis.
AuthorsFuchuan Guo, Conghui Huang, Xilu Liao, Yemei Wang, Ying He, Rennan Feng, Ying Li, Changhao Sun
JournalMolecular nutrition & food research (Mol Nutr Food Res) Vol. 55 Issue 12 Pg. 1809-18 (Dec 2011) ISSN: 1613-4133 [Electronic] Germany
PMID22038976 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
Chemical References
  • CD36 Antigens
  • Carrier Proteins
  • Dietary Fats
  • Fatty Acids, Nonesterified
  • Hypolipidemic Agents
  • PPAR alpha
  • RNA, Messenger
  • Sterol Regulatory Element Binding Protein 1
  • Triglycerides
  • Xanthones
  • microsomal triglyceride transfer protein
  • mangiferin
  • Diacylglycerol O-Acyltransferase
  • Carnitine O-Palmitoyltransferase
  • Lipoprotein Lipase
  • Acetyl-CoA Carboxylase
Topics
  • Acetyl-CoA Carboxylase (drug effects, genetics, metabolism)
  • Adipose Tissue (drug effects)
  • Animals
  • Body Weight (drug effects)
  • CD36 Antigens (drug effects, genetics, metabolism)
  • Carnitine O-Palmitoyltransferase (drug effects, genetics, metabolism)
  • Carrier Proteins (drug effects, genetics, metabolism)
  • Cricetinae
  • Diacylglycerol O-Acyltransferase (drug effects, genetics, metabolism)
  • Diet, High-Fat
  • Dietary Fats (administration & dosage)
  • Down-Regulation
  • Fatty Acids, Nonesterified (blood)
  • Hyperlipidemias (drug therapy)
  • Hypertriglyceridemia (drug therapy)
  • Hypolipidemic Agents (pharmacology)
  • Lipid Metabolism (drug effects, genetics)
  • Lipogenesis (drug effects, genetics)
  • Lipoprotein Lipase (drug effects, genetics, metabolism)
  • Liver (drug effects, metabolism)
  • Male
  • Organ Size (drug effects)
  • PPAR alpha (drug effects, genetics, metabolism)
  • RNA, Messenger (genetics, metabolism)
  • Sterol Regulatory Element Binding Protein 1 (drug effects, genetics, metabolism)
  • Triglycerides (blood)
  • Up-Regulation
  • Xanthones (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: